Prostate Pathology: Understanding the Challenges and Advances
We don't want to necessarily over-treat the patient, because we know that these patients will live with the cancer and die with it, but not from it.
Picture this: it’s the 1920s and Dr. Charles Huggins is knee-deep in metabolic experiments on dog prostates when he stumbles upon a peculiar discovery—prostatic cancer cells. Fast forward to 1966, and Huggins is awarded the Nobel Prize for Physiology or Medicine for his groundbreaking work. Prostate cancer is one of the most common malignancies among men, but many will die with it rather than from it.
This episode of 'This Pathological Life' dives deep into the history, diagnosis, and treatment of prostate pathology. Host Steve Davis teams up with resident pathologist Dr. Travis Brown to unpack the complexities of diagnosing prostate cancer. They shed light on the role of PSA testing and MRI scans, while also tackling the psychological barriers that patients often face when it comes to screening and treatment. The episode features an enlightening interview with Dr.
Bradley Webster, a histopathologist specializing in uropathology and lymphoid pathology. Dr. Webster discusses the importance of not overtreating patients with low-grade tumors and explores the potential benefits of molecular testing. With a blend of historical context, expert insights, and a patient-centric approach, this episode is a must-listen for anyone keen on understanding the nuances of prostate pathology.